The Promises of Quantitative Proteomics in Precision Medicine

about

Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics.

P2860

Q47917027-8D090CD0-0A89-41A3-802E-E3A484CFDDBD

P2860

The Promises of Quantitative Proteomics in Precision Medicine

Item

http://www.wikidata.org/entity/Q37647264

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Promises of Quantitative Proteomics in Precision Medicine

@en

The Promises of Quantitative Proteomics in Precision Medicine.

@nl

type

Item

label

The Promises of Quantitative Proteomics in Precision Medicine

@en

The Promises of Quantitative Proteomics in Precision Medicine.

@nl

prefLabel

The Promises of Quantitative Proteomics in Precision Medicine

@en

The Promises of Quantitative Proteomics in Precision Medicine.

@nl

P1476

The Promises of Quantitative Proteomics in Precision Medicine

@en

P2093

Aanchal Mehrotra

http://www.w3.org/2001/XMLSchema#string

Bhagwat Prasad

http://www.w3.org/2001/XMLSchema#string

Deepak Kumar Bhatt

http://www.w3.org/2001/XMLSchema#string

Katherine Johnson

http://www.w3.org/2001/XMLSchema#string

Marc Vrana

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome P450-dependent catabolism of vitamin K: ω-hydroxylation catalyzed by human CYP4F2 and CYP4F11

Epigenetics: the science of change

microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment

The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs

Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics

Proteomics in epigenetics: new perspectives for cancer research

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

Developmental aspects of human hepatic drug glucuronidation in young children and adults

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

VKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: transthyretin precursor as a potential biomarker

P304

738-744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.XPHS.2016.11.017

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27939376

http://www.w3.org/2001/XMLSchema#string

P932

5313344

http://www.w3.org/2001/XMLSchema#string

The Promises of Quantitative Proteomics in Precision Medicine

about

P2860

P2860

The Promises of Quantitative Proteomics in Precision Medicine

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932